Development of Tigecycline Resistance in Carbapenemase-Producing Klebsiella pneumoniae Sequence Type 147 via AcrAB Overproduction Mediated by Replacement of the ramA Promoter
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Carbapenem-resistant K. pneumoniae 2297, isolated from a patient treated with tigecycline for pneumonia, developed tigecycline resistance, in contrast to carbapenem-resistant isolate 1215, which was collected four months prior to the 2297 isolate. Mechanisms underlying tigecycline resistance were elucidated for the clinical isolates. Methods: The tigecycline minimum inhibitory concentration (MIC) was determined using the broth microdilution method, with or without phenylalanine–arginine β-naphthylamide (PABN), and whole-genome sequencing was carried out by single-molecule real-time sequencing. The expression levels of the genes acrA, oqxA, ramA, rarA, and rpoB were determined by reverse-transcription quantitative PCR. Results: Both isolates presented identical antibiograms, except for tigecycline, which showed an MIC of 0.5 mg/L in 1215 and 2 mg/L in 2297. The addition of PABN to tigecycline-resistant 2297 caused a four-fold decrease in the tigecycline MIC to 0.5 mg/L, although acrA expression (encoding the AcrAB efflux pump) was upregulated by 2.5 fold and ramA expression (encoding the pump activator RamA) was upregulated by 1.4 fold. We identified a 6,096-bp fragment insertion flanking direct TATAT repeats that disrupted the romA gene located upstream of ramA in the chromosome of K. pneumoniae 2297; the insertion led the ramA gene promoter replacement resulting in stronger activation of the gene. Conclusions: The K. pneumoniae isolate developed tigecycline resistance during tigecycline treatment. It was related to the overexpression of the AcrAB resistance-nodulation-cell division efflux system due to promoter replacement.
Abstract
Background: Carbapenem-resistant K. pneumoniae 2297, isolated from a patient treated with tigecycline for pneumonia, developed tigecycline resistance, in contrast to carbapenem-resistant isolate 1215, which was collected four months prior to the 2297 isolate. Mechanisms underlying tigecycline resistance were elucidated for the clinical isolates. Methods: The tigecycline minimum inhibitory concentration (MIC) was determined using the broth microdilution method, with or without phenylalanine–arginine β-naphthylamide (PABN), and whole-genome sequencing was carried out by single-molecule real-time sequencing. The expression levels of the genes acrA, oqxA, ramA, rarA, and rpoB were determined by reverse-transcription quantitative PCR. Results: Both isolates presented identical antibiograms, except for tigecycline, which showed an MIC of 0.5 mg/L in 1215 and 2 mg/L in 2297. The addition of PABN to tigecycline-resistant 2297 caused a four-fold decrease in the tigecycline MIC to 0.5 mg/L, although acrA expression (encoding the AcrAB efflux pump) was upregulated by 2.5 fold and ramA expression (encoding the pump activator RamA) was upregulated by 1.4 fold. We identified a 6,096-bp fragment insertion flanking direct TATAT repeats that disrupted the romA gene located upstream of ramA in the chromosome of K. pneumoniae 2297; the insertion led the ramA gene promoter replacement resulting in stronger activation of the gene. Conclusions: The K. pneumoniae isolate developed tigecycline resistance during tigecycline treatment. It was related to the overexpression of the AcrAB resistance-nodulation-cell division efflux system due to promoter replacement.
참고문헌 (25)
- Pendleton JN, "Clinical relevance of the ESKAPE pathogens", Expert Rev Anti Infect Ther, 11, pp.297~298 (2013)
- Pitout JD, "Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance", Antimicrob Agents Chemother, 59, pp.5873~5884 (2015)
- Livermore DM, "Tigecycline: what is it, and where should it be used?", J Antimicrob Chemother, 56, pp.611~614 (2005)
- Dean CR, "Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1", Antimicrob Agents Chemother, 47, pp.972~978 (2003)
- Hornsey M, "Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome", J Antimicrob Chemother, 65, pp.479~482 (2010)
- Veleba M, "Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes", J Antimicrob Chemother, 68, pp.1011~1018 (2013)
- Hirata T, "Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)", Antimicrob Agents Chemother, 48, pp.2179~2184 (2004)
- Veleba M, "Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae", Antimicrob Agents Chemother, 56, pp.4466~4467 (2012)
- Ruzin A, "Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae", Antimicrob Agents Chemother, 49, pp.1017~1022 (2005)
- De Majumdar S, "Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae", Antimicrob Agents Chemother, 57, pp.1603~1609 (2013)
- Cho SY, "Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea", Emerg Infect Dis, 21, pp.1088~1089 (2015)
- Du X, "The Rapid Emergence of Tigecycline Resistance in blaKPC-2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment", Front Microbiol, 9, pp.648~ (2018)
- Diancourt L, "Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates", J Clin Microbiol, 43, pp.4178~4182 (2005)
- "Antimicrobial susceptibility testing of bacteria"[URL]
- "Breakpoint tables for interpretation of MICs and zone diameters. version 7.1"[URL]
- Poirel L, "Multiplex PCR for detection of acquired carbapenemase genes", Diagn Microbiol Infect Dis, 70, pp.119~123 (2011)
- Altschul SF, "Gapped BLAST and PSI-BLAST : a new generation of protein database search programs", Nucleic Acids Res, 25, pp.3389~3402 (1997)
- Zankari E, "Identification of acquired antimicrobial resistance genes", J Antimicrob Chemother, 67, pp.2640~2644 (2012)
- Carattoli A, "In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing", Antimicrob Agents Chemother, 58, pp.3895~3903 (2014)
- Komatsu T, "Increased resistance to multiple drugs by introduction of the Enterobacter cloacae romA gene into OmpF porin-deficient mutants of Escherichia coli K-12", Antimicrob Agents Chemother, 35, pp.2155~2158 (1991)
- Rosenblum R, "Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae", Int J Antimicrob Agents, 38, pp.39~45 (2011)
- Bauer G, "Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA", J Antimicrob Chemother, 53, pp.592~599 (2004)
- Fang L, "Step-Wise increase in tigecycline resistance in Klebsiella pneumoniae associated with mutations in ramR, lon and rpsJ", PLoS One, 11, pp.e0165019~ (2016)
- D. van Duin, "Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance", Clinical Microbiology and Infection, 20(12), pp.O1117~O1120 (2014), Elsevier BV[DOI]
- Nigo M, "Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae", Antimicrob Agents Chemother, 57, pp.5743~5746 (2013)